Stockscreener 앱 받기
3.22
1.90%
0.06
전일 마감가:
$3.16
열려 있는:
$3.06
하루 거래량:
20,066
Relative Volume:
0.13
시가총액:
$7.26M
수익:
$1.23M
순이익/손실:
$-8.26M
주가수익비율:
-0.8314
EPS:
-3.8732
순현금흐름:
$-14.65M
1주 성능:
+2.22%
1개월 성능:
+21.05%
6개월 성능:
-14.81%
1년 성능:
-37.60%
1일 변동 폭
$3.06
$3.25
1주일 범위
$3.05
$3.38
52주 변동 폭
$1.71
$8.5961
SINTX 테크놀로지스 Stock (SINT) Company Profile
명칭
Sintx Technologies Inc
전화
801-839-3516
주소
1885 WEST 2100 STREET, SALT LAKE CITY, UT
SINT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SINT
Sintx Technologies Inc
|
3.22 | 7.26M | 1.23M | -8.26M | -14.65M | -3.8732 |
|
ABT
Abbott Laboratories
|
134.38 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
106.53 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
393.55 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
86.02 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.21 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
SINTX 테크놀로지스 Stock (SINT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-09-12 | 개시 | Ascendiant Capital Markets | Buy |
SINTX 테크놀로지스 주식(SINT)의 최신 뉴스
SINTX Technologies (SINT) Enhances Strategic Vision to Boost Gro - GuruFocus
SINTX Technologies outlines new strategy to commercialize silicon nitride By Investing.com - Investing.com South Africa
SINTX Technologies Unveils Strategic Vision To Expand Commercialization Across Key Markets - Nasdaq
SINTX Technologies outlines new strategy to commercialize silicon nitride - Investing.com
SINTX Technologies Announces Strategic Vision Focused on Expansion Across Key Sectors | SINT Stock News - GuruFocus
SINTX Technologies Announces Strategic Vision Focused on Expansion Across Key Sectors - GlobeNewswire
Sintx Technologies (NASDAQ:SINT) Price Target Lowered to $28.00 at Ascendiant Capital Markets - Defense World
SINTX Technologies (SINT) Rating Maintained as Price Target Adju - GuruFocus
Ascendiant cuts SINTX Tech price target to $28, keeps Buy rating By Investing.com - Investing.com South Africa
Ascendiant cuts SINTX Tech price target to $28, keeps Buy rating - Investing.com India
SINTX Technologies (SINT) Rating Maintained as Price Target Adjusted | SINT Stock News - GuruFocus
Sintx Technologies Draws Heavy Retail Buzz On New Patent Push, Subsidiary - MSN
Sintx Technologies Draws Heavy Retail Buzz On New Patent Push, Subsidiary By Stocktwits - Investing.com India
SINTX Technologies expands into agribiotech with new patent - Investing.com Australia
SINTX Technologies expands into agribiotech with new patent By Investing.com - Investing.com South Africa
SINTX Technologies Receives Patent for Antimicrobial Agribiotech Product - mg Magazine
SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market - Koreabizwire
SINTX (SINT) Expands into Agribiotech with New Patent and Subsid - GuruFocus
SINTX Technologies, Inc. Launches Agribiotech Subsidiary Following International Patent Issuance for Silicon Nitride Applications in Agriculture - Nasdaq
SINTX Technologies Announces Patent Issuance and Formation - GlobeNewswire
This Penny Stock Is Surging on Patent News. Analysts Think It Gain 1,300% From Here. - The Globe and Mail
SINTX Technologies Inc reports results for the quarter ended March 31Earnings Summary - TradingView
SINTX Technologies refocuses on medical device market By Investing.com - Investing.com Nigeria
SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization - GlobeNewswire
SINTX Technologies (SINT) Advances as a Medical Device Innovator - GuruFocus
SINTX Technologies refocuses on medical device market - Investing.com
SINTX Technologies (SINT) Advances as a Medical Device Innovator | SINT Stock News - GuruFocus
SINTX Technologies Provides Business Update Highlighting Strateg - GuruFocus
SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization | SINT Stock News - GuruFocus
SINTX Technologies, Inc. Updates Investors on Strategic Shift to Medical Device Market and Financial Position for Q1 2025 - Nasdaq
Sintx Technologies, Inc. SEC 10-Q Report - TradingView
Sintx technologies director Mark Anderson purchases $11,800 in stock By Investing.com - Investing.com Nigeria
Sintx technologies director Mark Anderson purchases $11,800 in stock - Investing.com
Sintx Technologies (SINT) Expected to Announce Quarterly Earnings on Monday - Defense World
Sintx Technologies (SINT) Projected to Post Earnings on Monday - The AM Reporter
SINTX Technologies Inc expected to post a loss of 75 cents a shareEarnings Preview - TradingView
Renaissance Technologies LLC Purchases Shares of 21,900 Sintx Technologies, Inc. (NASDAQ:SINT) - Defense World
Sintx Technologies Approves New Executive Agreements - TipRanks
SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial - SDx Central
Sintx technologies chief strategy officer buys $7,160 in stock By Investing.com - Investing.com India
Sintx technologies chief strategy officer buys $7,160 in stock - Investing.com
Sintx Technologies, Inc. (NASDAQ:SINT) Sees Significant Increase in Short Interest - Defense World
Sintx technologies’ chief strategy officer acquires $17,666 in stock By Investing.com - Investing.com South Africa
Sintx technologies’ chief strategy officer acquires $17,666 in stock - Investing.com Australia
Sintx technologies CEO Eric Olson buys $28,087 in stock - Investing.com
Sintx Technologies Executives Increase Holdings - TradingView
Sintx Technologies (NASDAQ:SINT) Given New $30.00 Price Target at Ascendiant Capital Markets - Defense World
Sintx Technologies Appoints Five New Board Directors - TipRanks
SINTX 테크놀로지스 (SINT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
SINTX 테크놀로지스 주식 (SINT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Anderson Mark Lewis | Director |
Apr 24 '25 |
Buy |
2.36 |
5,000 |
11,800 |
5,000 |
| Honigblum Gregg R. | Chief Strategy Officer |
Apr 22 '25 |
Buy |
1.79 |
4,000 |
7,160 |
14,000 |
| Olson Eric K. | President and CEO |
Apr 23 '25 |
Buy |
1.94 |
14,264 |
27,680 |
14,500 |
| Olson Eric K. | President and CEO |
Apr 22 '25 |
Buy |
1.73 |
236 |
408 |
236 |
| Honigblum Gregg R. | Chief Strategy Officer |
Apr 22 '25 |
Buy |
1.77 |
10,000 |
17,666 |
10,000 |
1.05%
0.64%
자본화:
|
볼륨(24시간):